BRD4 and neoplasm: Univariate survival analysis revealed that, in addition to clinical stage, tumor differentiation, nervous invasion and vessel invasion, high BRD4 (HR = 3.321, p = 0.001) and CAV-2 expression (HR = 3.666, p < 0.001) predicted poor prognosis (Table 3).